{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:13:42Z","timestamp":1779887622319,"version":"3.53.1"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institute for Social Security and Services for State Workers (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, ISSSTE)"},{"name":"Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas and Merz Therapeutics GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Osteoarthritis (OA) is the most prevalent rheumatologic disease and a leading cause of years lived with disability worldwide. There are no disease-modifying drugs available to treat it. This study aimed to evaluate the effect of a single dose of 100U botulinum neurotoxin-A (BoNT-A) in patients with early knee OA. We designed a single-arm preliminary clinical trial in patients diagnosed with knee OA (KOA) grades I and II. 45 Patients received a single dose of 100U IncobotulinumtoxinA in the retro-patellar bursa and received nutritional and physical rehabilitation indications. Patients were evaluated at baseline and at days 5, 30, 60, and 90 after injection. The primary outcome was the reduction in pain using the visual analog scale (VAS). Knee function was evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). We assessed secondary adverse effects and measured muscular strength in every consultation. Descriptive endpoint summaries and a generalized linear random-effect model were used to evaluate changes in each follow-up time compared to baseline. IncobotulinumtoxinA treatment significantly (p &lt; 0.001) reduced pain in all treated patients at day 90 compared to day 0. Patients showed a significant reduction in total WOMAC score (p &lt; 0.001), from a mean baseline of 44.6 (95% CI; 41.4, 47.8) to 4.4 at day 90 (95% CI; 0.2, 0.3). Our results show that IncobotulinumtoxinA applied in the retro-patellar bursa is a safe and effective treatment for pain in patients with early-stage KOA, offering a potential alternative for symptomatic control in KOA.<\/jats:p>","DOI":"10.3390\/toxins17050216","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:08:24Z","timestamp":1745554104000},"page":"216","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-Dose IncobotulinumtoxinA in the Treatment of Early-Stage Knee Osteoarthritis: Results from a Preliminary Single-Arm Clinical Trial"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0492-8386","authenticated-orcid":false,"given":"Sofia","family":"Dur\u00e1n-Hern\u00e1ndez","sequence":"first","affiliation":[{"name":"Hospital General Tacuba, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Profesor de Asignatura, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM), Mexico City 04360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma E.","family":"Herrera-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional (IPN), Mexico City 11340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4253-0387","authenticated-orcid":false,"given":"Nayar","family":"Dur\u00e1n-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center (DRFZ), Leibniz Institute, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Carnalla","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n en Salud Poblacional, Instituto Nacional de Salud P\u00fablica, Cuernavaca 62100, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8689-9755","authenticated-orcid":false,"given":"Manuel de Jes\u00fas","family":"Castillejos-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Investigador, Unidad de Vigilancia Epidemiol\u00f3gica, INER Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Citlaltepetl","family":"Salinas-Lara","sequence":"additional","affiliation":[{"name":"Departamento de Neuropatolog\u00eda, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda (INNN), Mexico City 14269, Mexico"},{"name":"Red MEDICI Carrera de M\u00e9dico Cirujano, FES Iztacala, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM), Mexico City 54090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"ref_1","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390, 1211\u20131259."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","article-title":"Global, regional and national burden of osteoarthritis 1990\u20132017: A systematic analysis of the Global Burden of Disease Study 2017","volume":"79","author":"Safiri","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: A disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrrheum.2013.72","article-title":"Post-traumatic osteoarthritis: From mouse models to clinical trials","volume":"9","author":"Little","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.joca.2020.10.004","article-title":"Visual Analogue Scale has higher assay sensitivity than WOMAC pain in detecting between-group differences in treatment effects: A meta-epidemiological study","volume":"29","author":"Saadat","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02032362","article-title":"A Preliminary Evaluation of the Dimensionality and Clinical Importance of Pain and Disability in Osteoarthritis of the Hip and Knee","volume":"5","author":"Bellamy","year":"1986","journal-title":"Clin. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.24235","article-title":"Measures of Adult Knee Function","volume":"72","author":"McHugh","year":"2020","journal-title":"Arthritis Care Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/annrheumdis-2020-217363","article-title":"Does cartilage loss cause pain in osteoarthritis and if so, how much?","volume":"79","author":"Bacon","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.joca.2015.04.018","article-title":"Severe radiographic knee osteoarthritis e does Kellgren and Lawrence grade 4 represent end stage disease?\u2014The MOST study","volume":"23","author":"Guermazi","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.joca.2015.02.163","article-title":"Pain sensitization in people with knee osteoarthritis: A systematic review and meta-analysis","volume":"23","author":"Fingleton","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Blanshan, N., and Krug, H. (2020). The use of botulinum toxin for the treatment of chronic joint pain: Clinical and experimental evidence. Toxins, 12.","DOI":"10.3390\/toxins12050314"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of Botulinum Toxin in Spasmodic Torticollis","volume":"328","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1526-4637.2011.01245.x","article-title":"Treatment of Refractory Pain with Botulinum Toxins-An Evidence-Based Review","volume":"12","author":"Jabbari","year":"2011","journal-title":"Pain Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e027953","DOI":"10.1136\/bmjopen-2018-027953","article-title":"Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine","volume":"9","author":"Herd","year":"2019","journal-title":"BMJ Open"},{"key":"ref_20","first-page":"e2","article-title":"The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: A Systematic Literature Review","volume":"11","author":"Anton","year":"2020","journal-title":"J. Oral. Maxillofac. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"107208","DOI":"10.1016\/j.toxicon.2023.107208","article-title":"Botulinum toxin A and neuropathic pain: An update","volume":"232","author":"Spagna","year":"2023","journal-title":"Toxicon"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","article-title":"Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): A randomised, double-blind, placebo-controlled trial","volume":"15","author":"Attal","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Val, M., Delcanho, R., Ferrari, M., Nardini, L.G., and Manfredini, D. (2023). Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review. Toxins, 15.","DOI":"10.3390\/toxins15090541"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","article-title":"Botulinum toxin treatment of pain syndromes\u2014An evidence based review","volume":"147","author":"Safarpour","year":"2018","journal-title":"Toxicon"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Park, J.H., and Park, H.J. (2017). Botulinum toxin for the treatment of neuropathic pain. Toxins, 9.","DOI":"10.3390\/toxins9090260"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"802893","DOI":"10.1155\/2012\/802893","article-title":"Therapeutic use of botulinum toxin in neurorehabilitation","volume":"2012","author":"Intiso","year":"2012","journal-title":"J. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1474-4422(16)00056-9","article-title":"Fighting neuropathic pain with botulinum toxin A","volume":"15","author":"Baron","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03033937","article-title":"Long term effects of intra-articular botulinum toxin a for refractory joint pain","volume":"9","author":"Mahowald","year":"2006","journal-title":"Neurotox. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1526-4637.2009.00711.x","article-title":"Pain behavior measures to quantitate joint pain and response to neurotoxin treatment in murine models of arthritis","volume":"10","author":"Krug","year":"2009","journal-title":"Pain Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/JPR.S12520","article-title":"Analgesic effects of intra-articular botulinum toxin Type B in a murine model of chronic degenerative knee arthritis pain","volume":"3","author":"Anderson","year":"2010","journal-title":"J. Pain Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.trsl.2009.02.004","article-title":"Intra-articular botulinum toxin A for refractory shoulder pain: A randomized, double-blinded, placebo-controlled trial","volume":"153","author":"Singh","year":"2009","journal-title":"Transl. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pmrj.2010.02.011","article-title":"Efficacy of Intra-Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot Study","volume":"2","author":"Boon","year":"2010","journal-title":"PM&R"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.pmrj.2016.05.009","article-title":"Effects of Botulinum Toxin Landmark-Guided Intra-articular Injection in Subjects with Knee Osteoarthritis","volume":"8","author":"Hsieh","year":"2016","journal-title":"PM&R"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2340\/16501977-2340","article-title":"Effect of therapeutic exercise on knee osteoarthritis after intraarticular injection of botulinum toxin type a, hyaluronate or saline: A randomized controlled trial","volume":"50","author":"Bao","year":"2018","journal-title":"J. Rehabil. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MRR.0000000000000411","article-title":"Physical therapy, intra-articular dextrose prolotherapy, botulinum neurotoxin, and hyaluronic acid for knee osteoarthritis: Randomized clinical trial","volume":"43","author":"Rezasoltani","year":"2020","journal-title":"Int. J. Rehabil. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/03009742.2016.1203988","article-title":"Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: Effect on human mechanistic pain biomarkers and clinical pain","volume":"46","author":"Jiang","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.joca.2018.05.001","article-title":"Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: Results of a placebo-controlled, double-blind study","volume":"26","author":"McAlindon","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/0269215519827996","article-title":"Comparison between intra-articular Botulinum toxin type A, corticosteroid, and saline in knee osteoarthritis: A randomized controlled trial","volume":"33","author":"Mendes","year":"2019","journal-title":"Clin. Rehabil."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/bjsports-2020-102179","article-title":"Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: A systematic review and network meta-analysis of randomised controlled trials","volume":"55","author":"Gazendam","year":"2021","journal-title":"Br. J. Sports Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxicon.2019.04.003","article-title":"Intra-articular botulinum toxin type A for treatment of knee osteoarthritis: Clinical trial","volume":"165","author":"Najafi","year":"2019","journal-title":"Toxicon"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jbspin.2008.05.006","article-title":"Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: A report of two cases","volume":"76","author":"Singh","year":"2009","journal-title":"Jt. Bone Spine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/108155890405202S87","article-title":"Report on Intraarticular Botulinum Toxin Type a for Refractory Joint Pain","volume":"52","author":"Mahowald","year":"2004","journal-title":"J. Investig. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100456","DOI":"10.1016\/j.ocarto.2024.100456","article-title":"The effects of exercise and intra-articular injections versus exercise alone for the treatment of knee osteoarthritis: A scoping review of the evidence","volume":"6","author":"Liles","year":"2024","journal-title":"Osteoarthr. Cart. Open"},{"key":"ref_44","unstructured":"Secretar\u00eda De Salud (2024, December 08). Prevenci\u00f3n, Diagn\u00f3stico y Tratamiento de Rehabilitaci\u00f3n en el Paciente Adulto con Osteoartrosis de Rodilla en los Tres Niveles de Atenci\u00f3n. Secretar\u00eda de Salud, Available online: http:\/\/www.cenetec-difusion.com\/CMGPC\/IMSS-726-14\/RR.pdf."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semarthrit.2016.04.003","article-title":"Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: A systematic review and meta-analysis of randomized trials","volume":"46","author":"Altman","year":"2016","journal-title":"Semin. Arthritis. Rheum."},{"key":"ref_46","unstructured":"Secretar\u00eda De Salud (2024, December 08). Diagn\u00f3stico, Tratamiento y Prevenci\u00f3n de Sobrepeso y Obesidad en el Adulto. Secretar\u00eda de Salud., Available online: http:\/\/www.facmed.unam.mx\/sg\/css\/GPC\/SIDSS-GPC\/gpc\/docs\/IMSS-046-08-RR.pdf."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/5\/216\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:21:10Z","timestamp":1760030470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/5\/216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["toxins17050216"],"URL":"https:\/\/doi.org\/10.3390\/toxins17050216","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}